Great Point Partners LLC Dyne Therapeutics, Inc. Transaction History

Great Point Partners LLC

  • $216 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$6.52 - $12.27 $5.51 Million - $10.4 Million
-845,000 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$11.89 - $16.07 $1.19 Million - $1.61 Million
100,000 Added 13.42%
845,000 $10 Million
Q3 2021

Nov 15, 2021
BUY
$15.6 - $21.46 $1.13 Million - $1.55 Million
72,441 Added 10.77%
745,000 $12.1 Million
Q2 2021

Aug 16, 2021
BUY
$15.94 - $22.33 $10.7 Million - $15 Million
672,559 New
672,559 $14.2 Million

Others Institutions Holding DYN

# of Institutions
207
Shares Held
102M
Call Options Held
234K
Put Options Held
238K
View Full List

About Dyne Therapeutics, Inc.

DYN Quotes by TradingView
  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $736M
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email